Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

  • By

  • Kerri Miller, Editor

  • July 26, 2024

  • 3 min

Share

Objective:

To analyze the medical and educational debt of U.S. health care workers compared to other workers.

Approach:
  • Study Design: Cross-sectional study using data from the Survey of Income and Program Participation (SIPP) from 2018 to 2021.
  • Participants: 8,018 health care workers (weighted n = 12.6 million) and 53,346 other workers (weighted n = 83.2 million).
  • Data Analysis: Logistic regression models estimated associations between indebtedness and various demographic and occupational variables.
Key Findings:
  • 13.9% of health care workers reported medical debt vs. 11.1% of other workers.
  • Mean medical debt for health care workers was $1,567, totaling $19.8 billion nationally.
  • 26.7% of health care workers reported educational debt vs. 16.5% of other workers, with an average debt of $10,642, totaling $134.4 billion nationally.
  • Medical debt was more prevalent among women (15.3%) and Black workers (19.7%).
  • Educational debt was disproportionately higher among Black and younger health care workers.
Interpretation:

Limitations:
  • Potential recall bias from self-reported data.
  • Possible underestimation of debt size due to top coding.
  • Lack of data on debt creditors.
Conclusion:

Sources:

Original Source(s)

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

  • by Kerri Miller, Editor

  • July 26, 2024

Related Content

Four Patterns in End-of-Life Decline?

International cohort study found physical function declined most rapidly before mortality, while socioeconomic status was associated with more favorable multidomain trajectories.

2025 BP Guideline Could Reduce Mortality

Modeling of nationally representative US data suggested broader implementation of the AHA/ACC 's 2025 recommendations could expand antihypertensive treatment eligibility and reduce long-term mortality among high-risk adults.

Can Patients Switch to Biosimilar Aflibercept?

A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.